The first Australian-developed candidate to reach human trials, Vaxine began a Phase I trial in early July in Adelaide. The trial will test 40 healthy candidates and results are expected in six to eight weeks, according to the Australian Financial Review. “From there we will look to commence phase II and III trials straight away,” the company’s chairman...
The first COVID-19 vaccine to be developed in the southern hemisphere has progressed to human trials. But the company behind it is funded by the United States’ National Institute of Allergy and Infectious Diseases, so will it stay in Australia? Podcast: https://www.abc.net.au/radio/hobart/programs/mornings/tas-scientist-says-aus-on-track-for-covid19-vaccine-by-2021/12419466
South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic. The team is headed by Nikolai Petrovsky, Flinders University Professor and Research Director at Vaxine. https://news.flinders.edu.au/blog/2020/04/03/flinders-targets-covid-19-vaccine/ https://www.facebook.com/watch/?v=649677092269608